TY - JOUR
T1 - Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-ε4 allele in Latin Americans
T2 - Findings from the Maracaibo Aging Study
AU - Molero, Aldrin E.
AU - Pino-Ramírez, Gloria
AU - Maestre, Gladys E.
N1 - Funding Information:
Support for the present study was provided by CONICIT Grant G-97000726. B.S. Waleska Fulcado, Dr Alicex González, Glabenys Barroso, and Lizzie Ocando extracted the DNA and amplified APOE. Drs Marı́a Nava, Ledys Mata, and Ida Julia Ojeda performed the neuropsychiatric evaluations; psychologists Sabrina González, Yulissa Dickson, Elvilena Passeri, and Marı́a José Machado conducted the neuropsychologic tests; and Ms. Mallira Rodrı́guez managed the database. We gratefully acknowledge their continuing efforts in the project and thank Drs Karen Marder and Tulio A. Sulbarán for their support and encouragement.
Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2001/7/6
Y1 - 2001/7/6
N2 - An ongoing longitudinal study in Maracaibo, Venezuela, examined the interaction between apolipoprotein E (APOE) genotypes and Alzheimer's disease (AD) and vascular dementia (VD), evaluating age and gender as potential modifiers of risk. Overall, carriers of at least one ε4 allele were at higher risk for AD, not for VD; however, the risk was significant only for subjects older than 65, and it increased 10-fold in subjects older than 85. The risk of AD conferred by APOE-ε4, adjusted for age and stratified by gender, was significant only for women. No association was found between the ε-2 allele and AD or VD. The results support the notions that APOE-ε4 is relevant for late-onset, not early onset AD, and that age and gender act as modulators of this association.
AB - An ongoing longitudinal study in Maracaibo, Venezuela, examined the interaction between apolipoprotein E (APOE) genotypes and Alzheimer's disease (AD) and vascular dementia (VD), evaluating age and gender as potential modifiers of risk. Overall, carriers of at least one ε4 allele were at higher risk for AD, not for VD; however, the risk was significant only for subjects older than 65, and it increased 10-fold in subjects older than 85. The risk of AD conferred by APOE-ε4, adjusted for age and stratified by gender, was significant only for women. No association was found between the ε-2 allele and AD or VD. The results support the notions that APOE-ε4 is relevant for late-onset, not early onset AD, and that age and gender act as modulators of this association.
KW - Apolipoprotein E
KW - Caribbean
KW - Dementia
KW - Elderly
KW - Population-based
KW - Risk
UR - http://www.scopus.com/inward/record.url?scp=0035816502&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035816502&partnerID=8YFLogxK
U2 - 10.1016/S0304-3940(01)01911-5
DO - 10.1016/S0304-3940(01)01911-5
M3 - Article
C2 - 11516561
AN - SCOPUS:0035816502
SN - 0304-3940
VL - 307
SP - 5
EP - 8
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 1
ER -